The patent provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof.
Brief outline of the case
The proprietor and the opponents 1 and 2 appealed the decision of maintenance by the OD according to AR1.
The MR in opposition corresponds to the claims as granted with claims 8 and 11 deleted.